Szela Mary T bought TLSI
June 30, 2026 · Form 4 insider transaction
Szela Mary T bought 3,990 shares of TriSalus Life Sciences, Inc. at $3.87 per share, a transaction worth $15.4K. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
3,990
Price
$3.87
Total value
$15.4K
InsiderSzela Mary T
Role—
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateJune 30, 2026
Filing dateJuly 1, 2026
Shares owned after1,077,683
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents shares acquired by the Reporting Person through the Issuer's Employee Stock Purchase Plan in a transaction exempt under Rule 16b-3.